In a statement on its X handle on Thursday, the agency said the product, manufactured by Strides Arcolab Limited, an India-based company was discovered in both the Federal Capital Territory and Rivers State during surveillance activities conducted by its officials.
“The laboratory report of the analysis carried out on the product revealed that it contained Zero Active Pharmaceutical Ingredients. The product was also observed to have two different date markings.
“The Artemether and Lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by the bite of a mosquito. However, this medicine is not used to treat severe or complicated malaria,” it said.
The agency warned the public against using counterfeit or falsified medicines, noting that such products pose significant health risks because they do not meet regulatory standards.
It emphasised that such products often fail to effectively treat diseases or conditions that they are in and can lead to serious health consequences or death.
Comments
Post a Comment